Company Monitoring Page for Biogen

latest headlines for company on cafepharma

Nightstar becomes nightmare, but Biogen has bigger fish to fry
EP Vantage
Tue, 06/15/21 - 10:30 am
Tags:
Biogen, Nightstar Therapeutics, M&A, gene therapy, BIIB111, BIIB112
‘I’m just winging it’: Faced with confusing data on the new Alzheimer’s drug, doctors scramble to advise their patients
Stat
Mon, 06/14/21 - 10:13 am
Tags:
physicians, Biogen, Aduhelm, FDA, Alzheimer's disease
Forget Biogen: These 2 Under-the-Radar Biotechs Are Also Celebrating Breakthroughs
Motley Fool
Sun, 06/13/21 - 10:44 pm
Tags:
Biogen, Alkermes, Alpine Immune Sciences
Eli Lilly, Roche's Alzheimer's prospects, including flops, boosted in light of FDA's Aduhelm approval: analysts
Fierce Biotech
Fri, 06/11/21 - 12:10 pm
Tags:
Eli Lilly, Roche, Biogen, Alzheimer's disease, FDA, beta-amyloid plaque
80% of pharma workers think Aduhelm's approval was a mistake, survey says
Beckers Hospital Review
Thu, 06/10/21 - 11:50 pm
Tags:
Biogen, Aduhelm, FDA, Alzheimer's disease
Third member of FDA expert committee resigns over controversial Alzheimer’s therapy decision
Stat
Thu, 06/10/21 - 11:48 pm
Tags:
FDA, Alzheimer's disease, Biogen, Aduhelm
Senators lambast new Alzheimer’s drug’s price but give Janet Woodcock a free pass on the approval decision
Endpoints
Thu, 06/10/21 - 11:44 pm
Tags:
Senate, Biogen, Alzheimer's disease, Aduhelm, Janet Woodcock, FDA
AdComm exodus: 2nd expert quits over FDA approval of Biogen's Aduhelm
Fierce Biotech
Thu, 06/10/21 - 11:07 am
Tags:
FDA, Biogen, Alzheimer's disease, Aduhelm
Acumen rides aducanumab, amyloid and Alzheimer's waves on its IPO voyage
Fierce Biotech
Thu, 06/10/21 - 11:04 am
Tags:
Acumen, IPOs, Aduhelm, Biogen
Faced with historic launch, Biogen to ship Alzheimer's drug in 2 weeks as nearly 1K treatment sites stand ready to go
Fierce Pharma
Wed, 06/9/21 - 11:12 am
Tags:
Biogen, drug launches, Aduhelm, Alzheimer's disease
Biogen Alzheimer's approval could open the door for other similar drugs
BioPharma Dive
Wed, 06/9/21 - 11:11 am
Tags:
Biogen, Alzheimer's disease, drug development, aducanumab, Aduhelm
Confirming benefit of Biogen Alzheimer’s disease drug will take 8 years
MedCity News
Wed, 06/9/21 - 11:01 am
Tags:
Biogen, FDA, clinical trials, Aduhelm, Alzheimer's disease
Member of FDA’s expert panel resigns over controversial Alzheimer’s therapy approval
Stat
Tue, 06/8/21 - 09:56 pm
Tags:
Biogen, Aduhelm, Alzheimer's disease, FDA
Biogen Sinks Despite Raft of Analyst Upgrades
Motley Fool
Tue, 06/8/21 - 09:43 pm
Tags:
Biogen, Aduhelm, aducanumab, Alzheimer's disease
Ready, set, prescribe? Doctors detail why they'll deploy Biogen's new Alzheimer's drug—or not
Fierce Pharma
Tue, 06/8/21 - 12:31 pm
Tags:
Biogen, Aduhelm, aducanumab, physicians, Alzheimer's disease
Aducanumab approval: ‘We anticipate demand will be high’, says Alzheimer’s Association
Biopharma Reporter
Tue, 06/8/21 - 12:30 pm
Tags:
Biogen, aducanumab, Alzheimer's disease, Aduhelm
Biogen's 'shockingly broad' Aduhelm label—and $56K price—set up a $10B launch, analysts say
Fierce Pharma
Mon, 06/7/21 - 08:49 pm
Tags:
Biogen, aducanumab, Aduhelm, FDA, drug pricing, Alzheimer's disease
An extra twist in the FDA’s Alzheimer’s decision: no limits on which patients can get the drug
Stat
Mon, 06/7/21 - 08:47 pm
Tags:
Biogen, aducanumab, FDA, Alzheimer's disease, Aduhelm
U.S. FDA approves Biogen Alzheimer's drug
Reuters
Mon, 06/7/21 - 11:17 am
Tags:
Biogen, aducanumab, Alzheimer's disease, FDA
Biogen shares rise as FDA nears ruling on controversial Alzheimer's drug
Reuters
Mon, 06/7/21 - 11:05 am
Tags:
Biogen, FDA, aducanumab, Alzheimer's disease

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.